Skip to main content
Clinical Trials/NCT01998932
NCT01998932
Completed
Not Applicable

Clinical Study to Identify Biological Markers to Predict Wound Healing in Patients With Chronic Venous Ulceration of the Lower Limb

Imperial College London2 sites in 1 country28 target enrollmentNovember 2013
ConditionsVaricose Ulcer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Varicose Ulcer
Sponsor
Imperial College London
Enrollment
28
Locations
2
Primary Endpoint
Identification of Biomarkers Predictive of Ulcer Healing.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Chronic venous ulceration of the lower limb poses a significant problem to patients and healthcare providers alike. 1% of the population of Western countries have either an open or healed chronic venous ulcer.

However, the pathophysiological abnormalities are not entirely clear in how raised venous pressure translates into the changes seen in the skin culminating in an open ulcer. The standard treatment of this condition in the United Kingdom is to undertaken compression bandaging of the lower limb.

In order to further their knowledge of venous ulceration, the investigators seek to determine the biological profile of venous ulcers over a maximum of twenty-eight weeks and by dividing the groups into healing and non-healing wounds, the investigators may be able to demonstrate a difference in the biological profile.

This work may provide insights into predicting who will respond to treatment and targets for treatment in the future.

Detailed Description

Forty patients with chronic venous ulceration of the lower limb who meet the inclusion criteria will be entered into the study and assessed over a twenty week period with assessments at week 0, 1, 2, 4, 8, 12 and 20. Urine, serum and ulcer fluid will be sampled. If the ulcer has not healed, further assessments using an approved biological dressing will be undertaken at weeks 20, 21, 22, 23, 25 and 28 with further sampling of ulcer fluid, urine and serum. Samples will undergo metabolic profiling using established metabolic profiling techniques developed at Imperial College.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
June 2015
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female over the age of 18 years
  • Chronic venous ulceration - Defined as wound of greater than four weeks in duration between the foot and the ankle with an Ankle Brachial Pressure Index greater than 0.
  • Ulceration present for at least four weeks.
  • Colour venous duplex evidence of chronic venous insufficiency showing either reflux or obstruction.

Exclusion Criteria

  • Acute infection in the studied lower limb within the last four weeks
  • History of malignancy in the lower limb to be studied
  • History of connective tissue disease
  • Patients on medications that can cause immunosuppression - Corticosteroids, chemotherapy or radiotherapy for cancer and recombinant immunological medications.

Outcomes

Primary Outcomes

Identification of Biomarkers Predictive of Ulcer Healing.

Time Frame: 20 weeks

The primary outcome was biomarker identification via nuclear magnetic resonance spectroscopy and mass spectrometry. Outcome measure units - number of biomarkers predictive of ulcer healing.

Secondary Outcomes

  • Differential Biological Response in Non Healing Ulcers Treated With a Biological Dressing.(8 weeks)

Study Sites (2)

Loading locations...

Similar Trials